Chief Technology Officers
bit.bio launches ioScreen and names their first CTO
Drug discovery teams can now outsource industrial-scale CRISPR screening in human cells as the Cambridge biotech expands its service offer.
By Sofiah Nichole Salivio
•
4 min read
•
Yesterday